Last updated 39 days ago

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

750 patients around the world

Available in Brazil, Argentina, Chile, United States

Amgen

11Research sites

750Patients around the world

This study is for people with

Lung cancer

Non-small cell lung carcinoma

Requirements for the patient

To 100 Years

All Gender

Medical requirements

Sites

Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro

Recruiting

25 de mayo 174, Viedma, Río Negrowww.imoviedma.com.ar

Fundación Cori para la Investigación y Prevención del Cáncer - La Rioja

Recruiting

Dorrego 269, La Rioja

Hospital Británico de Buenos Aires - CABA

Recruiting

Perdriel 74, CABA, Buenos Aireshttps://www.hospitalbritanico.org.ar/

Instituto Argentino de Diagnóstico y Tratamiento - IADT

Recruiting

Marcelo Torcuato de Alvear 2346, C1122 CABA

Fundación Ars Médica - San Salvador de Jujuy

Recruiting

Independencia 1167, San Salvador de Jujuy, Jujuy

Sanatorio Parque - Rosario

Recruiting

Boulevard Oroño 860, Rosario, Santa Fe

Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires

Recruiting

Av. Crámer 1180, CABA, Buenos Aires

Hospital Italiano de La Plata

Recruiting

Av. 51 entre 29 y 30 Nro 1725, La Plata, Buenos Aires

Centro Oncológico Korben

Recruiting

Cdad. de La Paz 353, C1426 CABA, Argentina

Centro de Diagnóstico Investigación y Tratamiento - CEDIT - Salta

Recruiting

Santiago del Estero 1415, Salta Capital

CIDO SpA-Oncology

Recruiting

Temuco, Araucania, 4810218

StudyCodeBreaK 202

SponsorAmgen

Conditions

Non-small cell lung carcinomaLung cancer

Requirements

To 100 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT05920356